J. A. A. Hunter

Benign melanocytic naevi as a risk factor for malignant melanoma.

Anthony J. Swerdlow, John English, R. M. MacKie et al. · BMJ · 1986 · 346 citations · Full text

Dermoscopic Image, Cutaneous Malignant Melanoma, Skin Cancer +13

Acute PKCδ inhibition limits ischaemia–reperfusion injury in the aged rat heart: Role of GSK-3β

John C. Kostyak, J. A. A. Hunter, Donna H. Korzick · Cardiovascular Research · 2006 · 44 citations · Full text

The Prevalence of Skin Disorders in Renal Allograft Recipients Receiving Cyclosporin A Compared with Those Receiving Azathioprine

Mary H. Bunney, E. C. Benton, Bryce Barr et al. · Nephrology Dialysis Transplantation · 1990 · 37 citations

Receiving Azathioprine, Immunology, Cyclosporin A +22

Cutaneous malignant melanoma in Scotland

R.M. MacKie, J. A. A. Hunter · British Journal of Cancer · 1982 · 33 citations · Full text

Cutaneous Malignant Melanoma, Melanoma, Histopathology +4

Severe reaction to diphosphonate: implications for treatment of Paget's disease.

A. T. ELLIOTT, Todd W. Murray, R.M. MacKie et al. · BMJ · 1988 · 21 citations · Full text

Sleep, Pharmacology, Forensic Toxicology +6